Salicylic acid

Description

The product is identified by the SPL Code 34089-3. No additional specific description details are provided in the available data.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, cauliflower-like surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed and dried thoroughly prior to application. A tag patch is to be applied after a 24-hour period. Following the application, the tag patch must be removed. This procedure should be repeated every 24 hours for a duration of up to 14 days for the removal of tags and up to 12 weeks for warts, or until the condition has resolved.

To facilitate the removal process, it is recommended to apply a hot compress to the wart using warm water for approximately 5 minutes.

Contraindications

Use is contraindicated in the following situations:

Application on irritated skin or any area that is infected or reddened is prohibited due to the potential for exacerbating the condition. Additionally, the product should not be applied to moles, birthmarks, warts with hair growing from them, or warts located on the face or mucous membranes, as these areas may present increased risks of adverse reactions.

Warnings and Precautions

For external use only. It is imperative to keep this and all medications out of the reach of children. In the event of accidental ingestion, immediate professional assistance should be sought, or contact a Poison Control Center without delay.

Healthcare professionals should advise patients to discontinue use of this product and consult a physician if discomfort persists for more than 72 hours. Monitoring for prolonged symptoms is essential to ensure patient safety and appropriate management.

Side Effects

Patients should be aware that this product is for external use only. It is imperative to keep this and all medications out of reach of children. In the event of accidental ingestion, professional assistance should be sought immediately, or contact a Poison Control Center.

In clinical practice, if discomfort persists for more than 72 hours, patients are advised to discontinue use of the product and consult their healthcare provider.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Suai Wart Remover. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be closely monitored to ensure that this medication is kept out of reach. In the event of accidental ingestion, it is crucial to seek professional assistance or contact a Poison Control Center immediately. Proper storage of this product is essential to prevent access by children.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of SUAI WART REMOVER in pregnant patients, including safety concerns, dosage modifications, or special precautions for use during pregnancy. Healthcare professionals should consider the lack of data when prescribing this medication to women of childbearing potential and weigh the potential risks versus benefits. It is advisable to exercise caution and discuss alternative treatment options with pregnant patients or those planning to become pregnant.

Lactation

There is no specific information regarding nursing mothers or lactation considerations provided in the drug insert for SUAI WART REMOVER. Therefore, the effects on breastfed infants and the excretion of the drug in human milk are not established. Healthcare professionals should exercise caution when recommending this product to lactating mothers.

Renal Impairment

Patients with renal impairment may not have specific information regarding dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and individualized patient assessment. Regular monitoring of renal function is advisable to ensure patient safety and therapeutic efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of overdosage, it is crucial to note that the product is intended for external use only. Accidental ingestion may pose serious health risks, and immediate action is required.

Healthcare professionals should advise that this product, along with all medications, must be kept out of reach of children to prevent accidental ingestion. In the case of accidental ingestion, it is imperative to seek professional assistance without delay. Contacting a Poison Control Center is strongly recommended to ensure appropriate management and intervention.

Prompt recognition of symptoms associated with overdosage is essential for effective treatment. Healthcare providers should remain vigilant and prepared to manage any adverse effects that may arise from misuse or accidental ingestion.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to store this product out of the reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of keeping medications secure and inaccessible to ensure the safety of young individuals.

Storage and Handling

This product is supplied in configurations that ensure optimal handling and storage. It is essential to store this product out of the reach of children to prevent accidental ingestion or misuse.

For proper storage, it is recommended to maintain the product in a controlled environment, adhering to any specific temperature ranges as indicated in the product's labeling. Special handling requirements may apply, and healthcare professionals should refer to the product's specific guidelines to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with the application of a tag patch after 24 hours. The patch should be removed and the procedure repeated every 24 hours for a duration of up to 14 days for the removal of tags and warts, or up to 12 weeks for warts, until the condition has resolved.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Suai Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)